A new research letter in JAMA tells us that more new mothers are using GLP-1s for weight management. The rise of use in this context is dramatic – roughly 500% between 2022 and 2024. Note that these data come from Denmark. There, we estimate the per capita use of GLP-1s for obesity is somewhat less […]

